Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)

Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)

Nutritional therapy (NT) is a therapeutic option in the conservative treatment of chronic kidney disease (CKD) patients to delay the start of dialysis. The aim of this study was to evaluate the specific effect of ketoanalogs (KA)-supplemented diets for gut microbiota modulation. In a previous study...

Full description

Bibliographic Details
Main Authors:	Maria Teresa Rocchetti, Biagio Raffaele Di Iorio, Mirco Vacca, Carmela Cosola, Stefania Marzocco, Ighli di Bari, Francesco Maria Calabrese, Roberto Ciarcia, Maria De Angelis, Loreto Gesualdo
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Journal of Clinical Medicine
Subjects:	CKD intestinal microbiome ketoanalogs indoxyl sulfate p-cresyl sulfate very low protein diet
Online Access:	https://www.mdpi.com/2077-0383/10/4/840

Similar Items

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
by: Biagio Raffaele Di Iorio, et al.
Published: (2019-09-01)

Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-cresol Sulfate in Hemodialysis Patients: Results from an In Vitro Study and an In Vivo Pilot Trial (xuanro4-Nature 3.2)
by: Maria Teresa Rocchetti, et al.
Published: (2020-03-01)

Removal of Protein-Bound Uremic Toxins Using Binding Competitors in Hemodialysis: A Narrative Review
by: Vaibhav Maheshwari, et al.
Published: (2021-09-01)

-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
by: Hye Sun Hyun, et al.
Published: (2013-04-01)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
by: Ziad A. Massy, et al.
Published: (2011-07-01)

Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study)
by: Stefania Marzocco, et al.
Published: (2018-09-01)

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques
by: Emiko Sato, et al.
Published: (2017-12-01)

Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients
by: Shunsuke Ito, et al.
Published: (2014-02-01)

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
by: Yong Jin Lim, et al.
Published: (2021-02-01)

Indoxyl Sulfate, Not P-Cresyl Sulfate, is Associated with Advanced Glycation end Products in Patients on Long-Term Hemodialysis
by: Cheng-Jui Lin, et al.
Published: (2015-03-01)

Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
by: Suree Lekawanvijit
Published: (2018-09-01)

Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence
by: Adamowicz, K., et al.
Published: (2023)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
by: Ming-Hsien Tsai, et al.
Published: (2021-02-01)

Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study
by: Tjaša Herič, et al.
Published: (2021-03-01)

The Administration of the Synbiotic <i>Lactobacillus bulgaricus</i> 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model
by: Alonso Jerez-Morales, et al.
Published: (2021-03-01)

Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study
by: Yang Li, et al.
Published: (2019-07-01)

Unambiguous Characterization of <i>p</i>-Cresyl Sulfate, a Protein-Bound Uremic Toxin, as Biomarker of Heart and Kidney Disease
by: Rita Paroni, et al.
Published: (2019-10-01)

Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization
by: Iwona Filipska, et al.
Published: (2021-04-01)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
by: Olivier Deltombe, et al.
Published: (2019-07-01)

An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
by: Carmela Cosola, et al.
Published: (2021-05-01)

Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
by: Sheldon C. Leong, et al.
Published: (2016-11-01)

Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
by: Fumi Yamagami, et al.
Published: (2019-10-01)

Uremic Toxins in Organ Crosstalk
by: Jerome Lowenstein, et al.
Published: (2021-04-01)

Biological variation of major gut‐derived uremic toxins in the serum of healthy adult cats
by: Stacie Summers, et al.
Published: (2021-03-01)

pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro
by: Suguru Yamamoto, et al.
Published: (2021-02-01)

Fructooligosaccharide decreases the production of uremic toxin precursor through modulating gut microbes mediated tyrosine metabolism pathway
by: Jingbo Lu, et al.
Published: (2021-12-01)

Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways
by: Gabriela Ferreira Dias, et al.
Published: (2018-07-01)

Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease
by: Nagata D, et al.
Published: (2020-12-01)

Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
by: Eya Hamza, et al.
Published: (2020-09-01)

Indoxyl Sulfate, a Uremic Endotheliotoxin
by: Guillaume Lano, et al.
Published: (2020-04-01)

Indoxyl sulfate is associated with mortality after AKI – more evidence needed!
by: Steven Menez, et al.
Published: (2019-07-01)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
by: Huang JY, et al.
Published: (2016-11-01)

Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production
by: Yingyi Wang, et al.
Published: (2020-11-01)

The double‐edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation
by: Jia‐Rong Jheng, et al.
Published: (2018-06-01)

p-Cresyl Sulfate
by: Tessa Gryp, et al.
Published: (2017-01-01)

Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species’ Release
by: Simona Adesso, et al.
Published: (2019-05-01)

Uremic Toxicity of Indoxyl Sulfate
by: Niwa, Toshimitsu
Published: (2010)

The AST-120 Recovers Uremic Toxin-Induced Cognitive Deficit via NLRP3 Inflammasome Pathway in Astrocytes and Microglia
by: Lung-Chih Li, et al.
Published: (2021-09-01)

Changes in serum indoxyl sulfate levels after acute myocardial infarction and the correlation with kidney injury: an observational study
by: Shuhei Watanabe, et al.
Published: (2019-07-01)

Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate
by: Koji Matsuo, et al.
Published: (2015-08-01)

Cannot write session to /tmp/vufind_sessions/sess_a2hgf0huqjk36dik9evdqra4jb